Viking Therapeutics (VKTX) Reports In-Line Q2 EPS

Go back to Viking Therapeutics (VKTX) Reports In-Line Q2 EPS
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 6.01 -0.14 (2.28%)
Previous Close $6.15    52 Week High $5.17 
Open $6.19    52 Week Low $0.94 
Day High $6.19    P/E N/A 
Day Low $6.00    EPS $0.00 
Volume 367,830